Bariatric Devices Market: By Type; By Procedure; By Cause; By Device; By Geography - Forecast 2014-2020

  • ID: 3063578
  • Report
  • 180 pages
  • IndustryARC
1 of 4
Overweight may be caused due to more calorie intake, disorders, hereditary reasons, disease and also environment in some cases. Generally people with a BMI of 40 and above are considered as obese.

Weight loss surgery or bariatric surgery is the commonly used term for various procedures used in treatment of obese. Diet management and intake of pills and supplements are also used to treat obesity non-invasively. Bariatric surgery market can be segmented based on type of surgery, applications, diseases and also different equipment or devices used for the surgery. The treatment may be invasive and non-invasive performed by varied end users like hospitals, clinics/physicians, management centers.

The Global Bariatric Device market has been analyzed with respect to five parameters: by type, by procedure, by cause, by device and by geography. This segment is further divided into various sub segments and is being forecasted till 2020. Around 95% of the bariatric surgeries use invasive device while remaining 5% use non-invasive devices. The procedures or treatments which make use of bariatric devices are classified into 3 types, i.e., restriction surgery, combined surgery and malabsorptive procedures. Each of these has been analyzed in a detailed manner by geography (North America, Europe, Asia-Pacific, and Rest of the World) to provide in-depth information about the global scenario.

At present, Invasive surgery is opted by many as it helps reduce the postoperative pain, blood loss and also decreases scarring pain. Non-invasive surgery causes less damage to the skin and is performed at minute risks. Currently the demand for non-invasive surgery is low but expected to grow significantly in the near future. Non-invasive market is expected to grow at a CAGR of 17% for the next five years.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1. Global Bariatric Devices report- Market Report

2. Executive summary

3. Bariatric- Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Bench-marking
3.2.2. Patent Analysis
3.2.3. Top 5 Financials Analysis

4. Bariatric devices- Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition

5. Bariatric Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Opportunities Analysis
5.3. Product life-cycle
5.4. Pricing Analysis

6. Global Bariatric Devices Market – By type
6.1. Invasive
6.2. Less/non invasive

7. Global Bariatric Devices Market – classification
7.1. By Procedure
7.1.1. Restriction surgery
7.1.1.1. Laparoscopic adjustable Gastric Band
7.1.1.2. Vertical Banded Gastroplasty
7.1.2. Combined Surgery
7.1.2.1. Roux-en-Y gastric bypass (RYGBP)(distal/proxima)
7.1.2.1. Long Limb RYGBP
7.1.3. Malabsorptive Procedures
7.1.3.1. Biliopancreatic diversion (BPD).
7.1.3.1. Biliopancreatic diversion with duodenal switch.
7.2. By Cause
7.2.1. Calorie Intake
7.2.2. Hereditary
7.2.3. Disease Or Disorders
7.2.3.1. Obesity
7.2.3.2. Type 2 diabetes
7.2.3.3. (apnea, comobrid)
7.2.3.4. Environment Hypertension
7.2.3.5. Cardiac diseases
7.2.4. Others

8. Global Bariatric Devices Market- By Device
8.1. Gastric Banding
8.1.1. Gastric band
8.1.1.1. Adjustable
8.1.1.2. Dissector
8.1.1.3. Sutureless Port and Applier
8.1.1.4. Bladeless Trocars
8.1.1.5. Curved Shears
8.1.1.6. Vessel Sealing Devices
8.2. Gastric Bypass
8.2.1. Gastric Pouch Devices
8.2.2. Circular Staplers
8.2.3. Bladeless Trocars
8.2.4. Curved Shears
8.2.5. Others
8.3. Sleeve Gastrectomy
8.4. Laparoscopic Graspers

9. Emerging Technologies

10. Global Bariatric Devices Market -Geographic Analysis
10.1. North America
10.1.1. Canada
10.1.2. Mexico
10.1.3. USA
10.1.4. Others
10.2. Europe
10.2.1. France
10.2.2. Germany
10.2.3. Italy
10.2.4. Sweden
10.2.5. U.K
10.2.6. Others
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. Australia
10.3.5. Others
10.4. ROW
10.4.1. South Africa
10.4.2. South America
10.4.3. Russia
10.4.4. Saudi Arabia
10.4.5. Others

11. Market Entropy
11.1. New Product Launches
11.2. M&As, Collaborations, JVs and Partnerships

12. Company profiles
12.1. Allergan, Inc.
12.2. Aspire Bariatrics
12.3. C.R. Bard
12.4. Cousin Biotech
12.5. Covidien Plc
12.6. Endogastric Solutions, Inc.
12.7. Enteromedics, Inc.
12.8. Ethicon
12.9. Gelesis
12.10. Gi Dynamics, Inc.
12.11. Helioscopie Medical
12.12. Johnson & Johnson
12.13. Medtronic
12.14. Metacure
12.15. Olympus Corporation
12.16. Reshape Medical, Inc.
12.17. Silimed Ltd
12.18. Spatz Fgia, Inc.
12.19. Synovis Surgical
12.20. USGI Medical
12.21. Stryker Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

13. Appendix
13.1. Abbreviations
13.2. Sources
13.3. Research Methodology
13.4. Bibliography
13.5. Compilation of Expert Insights
13.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
1. In 2013, in the event hosted by American Society for Metabolic and Bariatric Surgery (ASMBS) and The Obesity Society, states that Obesity is linked to more than 60 chronic diseases.
2. According to the American Cancer Society, 572,000 Americans die of cancer each year, about one-third of these cancer deaths are linked to excess body weight, poor nutrition and/or physical inactivity
3. The Framingham Heart Study, a famous study for 44 years, estimated that excess body weight (including overweight and obesity), accounted for approximately 26 percent of cases of hypertension in men and 28 percent in women. If weight-loss occurs and a normal blood pressure is achieved, then blood pressure medications may be tapered or stopped.
4. In 2013, according to Stanford University School of Medicine studies show that there is an effective reduction in number of cardiac risk factors comparatively after the bariatric surgery.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll